Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
The Journal of Cell Biology|October 8, 1998
Regulated targeting of BAX to mitochondriaI S Goping, A Gross, J N Lavoie, et al.Journal of the American Chemical Society|July 18, 2001
The first stereoselective total synthesis of quinineG Stork, D Niu, R A Fujimoto, et al.The Journal of Cell Biology|July 1, 1982
Intracellular transport of the transmembrane glycoprotein G of vesicular stomatitis virus through the Golgi apparatus as visualized by electron microscope radioautographyJ J Bergeron, G J Kotwal, G Levine, et al.Leukemia|July 4, 2008
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cellsP Pérez-Galán, G Roué, M López-Guerra, et al.The Journal of Biological Chemistry|December 5, 1998
E1A-induced processing of procaspase-8 can occur independently of FADD and is inhibited by Bcl-2M Nguyen, P E Branton, S Roy, et al.Cell Death and Differentiation|January 4, 2001
BID-dependent and BID-independent pathways for BAX insertion into mitochondriaS C Ruffolo, D G Breckenridge, M Nguyen, et al.Oncogene|February 1, 1996
Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymeraseC A Boulakia, G Chen, F W Ng, et al.Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogueA A Patchett, R P Nargund, J R Tata, et al.Journal of Medicinal Chemistry|October 16, 1992
Highly potent, orally active diester macrocyclic human renin inhibitorsA E Weber, M G Steiner, P A Krieter, et al.Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor libraryT A Rano, Y Cheng, T T Huening, et al.Pageof 17